As obesity continues to rise, this integrated, patient-first model may define the future of healthcare.
Clinical
Posted inTreatment
Stroke isn’t the end: This 69-year-old woman’s recovery shows the power of timely rehab
With more than 1.8 million stroke cases annually, India is witnessing a sharp rise in post-stroke disability.
Posted inAwareness and Promotion, Treatment
Dengue crisis brewing in India: Are we prepared for what’s coming?
Dengue is caused by a virus spread by Aedes mosquitoes. 4.7 billion people may be at risk of contracting dengue by the end of the century.
Posted inClinical, Awareness and Promotion
IVF pregnancy doesn’t always mean a C-section: Here’s what you should know
The process of vaginal birth is also not going to change in spontaneous pregnancy and IVF pregnancy.
Posted inTreatment
Multiple sclerosis cases rising, here’s why women are at higher risk than men
Living with multiple sclerosis (MS) requires some important lifestyle changes alongside medical treatment.
Posted inTreatment, Products & Suppliers
Traya proves 3x more effective than Minoxidil in a new hair loss study
Traya is helping treat hair loss internally by identifying the root cause of hair loss. Traya’s Hair Regimen is more effective than Minoxidil alone.
Posted inTreatment
How can couples at risk for Down syndrome plan pregnancy safely?
Down syndrome occurs in approximately 1 in 700 births in India. The difficulties in development arises from an extra copy of chromosome 21.
Posted inClinical
Nanavati Max launches advanced orthopedics, spine and joint care institute
Nanavati  Max  Super  Speciality Hospital also houses one of Maharashtra’s first in‑hospital 3D‑printing laboratories.
Posted inTreatment
Ovarian cancer: How PARP inhibitors are leading the next treatment wave
PARP inhibitors have redefined the therapeutic landscape of advanced ovarian cancer, offering a powerful and personalized strategy rooted in the biology of DNA repair.
Posted inTreatment, Pharma
AstraZeneca India gets CDSCO nod for new breast cancer treatment
The approval reflects AstraZeneca’s continued leadership in precision oncology, helping in advance care by bringing innovative therapies rooted in science to help patients who need it the most